fbpx
QQQ
+ 4.25
359.70
+ 1.17%
DIA
+ 2.33
345.93
+ 0.67%
SPY
+ 4.31
431.15
+ 0.99%
TLT
-1.00
150.50
-0.67%
GLD
-0.56
169.65
-0.33%

Meet The Innovative Psychedelics Incubator By Tabula Rasa Ventures

June 2, 2020 3:39 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
Meet The Innovative Psychedelics Incubator By Tabula Rasa Ventures

Venture capital firm Tabula Rasa Ventures launched a psychedelics business incubator.

Psychedelic Builders, a three-month program, has taken on seven participants — three in the exploratory phase — along with four startups.

The goals of the incubator are to take psychedelic and psychedelic-adjacent startups and provide executive mentorship, increase diversity and inclusion within the psychedelic industry, and develop infrastructure for these entrepreneurs who won't have access to traditional capital, the company explained.

"This industry is still in its infancy, and Tabula Rasa Ventures's mission is to provide impact-driven value, so we see this as a perfect opportunity to do that – through the next generation of entrepreneurs," said Tabula Rasa Ventures Founder Marik Hazan.  

Some of the startups include companies like Psychedelic Insights, a business that provides private, single-day psychedelic sessions with psychological guidance for safe psychedelic experiences in Amsterdam; and Speak AI, a speech analysis software company that extracts insights like personality, tone, and clarity from audio, video, and text.

The firm is currently taking applications for its Fall 2020 program at psychedelic.builders.

For the latest in financial news, exclusive stories, memes follow Benzinga on Twitter, Facebook & Instagram. For the best interviews, stock market talk & videos, subscribe to Benzinga Podcasts and our YouTube channel.


Related Articles

Field Trip Health Heads To The Nasdaq As Wall Street Opens Up To 'Psychedelics Renaissance'

Excitement around psychedelics grows as major U.S. exchanges make room for more companies in the sector. read more

AOC Reintroduces Amendment To Allow For Federal Research Into Psychedelics

Rep. Alexandria Ocasio-Cortez is again pushing for legislation that would remove federal barriers to research the therapeutic potential of psychedelic substances like MDMA, psilocybin and ibogaine. read more

Quick Hits: Let's Get Psychedelic

This article by Sara Brittany Somerset was originally published on Cannabis & Tech Today, and appears here with permission. read more

Cybin Lands Conditional Approval To Become The First Psychedelics Company on The NYSE

Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF), a biotech company in the psychedelics space, announced on Thursday a conditional approval to list on the New York Stock Exchange. read more